[1] Jin S, Yang YT, and Bao W. Signaling Pathways in Thyroid Cancer. Vitamins and Hormones, 2018; 106, 501–515.
[2] Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid. 2016;26(1):1-133.
[3] FH Liu, SF Kuo, C Hsueh, TC Chao, and JD Lin. Postoperative recurrence of papillary thyroid carcinoma with lymph node metastasis. Journal of Surgical Oncology.2015; 112(2): 149–154.
[4] C Zhang, BJ Li , Z Liu, LL Wang, W Cheng. Predicting the factors associated with central lymph node metastasis in clinical node‑negative (cN0) papillary thyroid microcarcinoma. European Archives of Oto-Rhino-Laryngology.2020.
[5] F Cheng , YY Chen , L Zhu.Risk Factors for Cervical Lymph Node Metastasis of Papillary Thyroid Microcarcinoma: A Single-Center Retrospective Study. International Journal of Endocrinology. 2019.ArticleID8579828, 6 pages.
[6] Kim SK, Park I, Woo JW, Lee JH, Choe JH, Kim JH, et al. Predictive factors for lymph node metastasis in papillary thyroid microcarcinoma. Ann Surg Oncol. (2016) 23:2866–73.
[7] Kim YS. Patterns and predictive factors of lateral lymph node metastasis in papillary thyroid microcarcinoma. Otolaryngology-Head and Neck Surgery.2012;147(1) :15-19.
[8] ND Perrier, JD Brierley, and RM Tuttle. Differentiated and anaplastic thyroid carcinoma: major changes in the American Joint Committee on Cancer eighth edition cancer staging manual. CA Cancer J Clin.2018;68(1):55-63.
[9] Roh JL, Kim JM, Park CI. Lateral cervical lymph node metastases from papillary thyroid carcinoma: pattern of nodal metastases and optimal strategy for neck dissection. Ann Surg Oncol 2008;15(4):1177-82.
[10] Roh JL, Park JY, Park CI. Total thyroidectomy plus neck dissection in differentiated papillary thyroid carcinoma patients: pattern of nodal metastasis,
morbidity, recurrence, and postoperative levels of serum parathyroid hormone. Ann Surg 2007;245(4):604-10.
[11] Mulla MG, Knoefel WT, Gilbert J, McGregor A, Schulte KM. Lateral cervical lymph node metastases in papillary thyroid cancer: a systematic review of
imaging-guided and prophylactic removal of the lateral compartment. Clin Endocrinol 2012;77(1):126-31.
[12] Stack Jr BC, Ferris RL, Goldenberg D, Haymart M, Shaha A, Sheth S, et al. American Thyroid Association consensus review and statement regarding the anatomy, terminology, and rationale for lateral neck dissection in differentiated thyroid cancer. Thyroid 2012;22(5):501-508.
[13] Eskander A, Merdad M, Freeman JL, Witterick IJ. Pattern of spread to the lateral neck in metastatic well-differentiated thyroid cancer: a systematic
review and meta-analysis. Thyroid 2013;23(5):583-92.
[14] Lin DZ, Qu N, Shi RL, Lu ZW, Ji QH, Wu WL. Risk prediction and clinical model building for lymph node metastasis in papillary thyroid microcarcinoma. Onco Targets Ther. 2016; 9:5307–5316.
[15] Xu Y, Xu L, Wang J. Clinical predictors of lymph node metastasis and survival rate in papillary thyroid microcarcinoma: analysis of 3,607 patients at a single institution. J Surg Res. 2018; 221:128–134.
[16] Grogan, RH. et al. A study of recurrence and death from papillary thyroid cancer with 27 years of median follow-up. Surgery. 2013;154(6), 1436–1446.
[17] Chéreau, N. et al. Recurrence of papillary thyroid carcinoma with lateral cervical node metastases: Predictive factors and operative management. Surgery. 2016;159(3), 755–762.
[18] So YK, Kim MJ, Kim S, Son YI. Lateral lymph node metastasis in papillary thyroid carcinoma: A systematicreview and meta-analysis for prevalence, risk factors, and location. International Journal of Surgery.2018; 50:94–103.
[19] T Qiao, Y Fan, AF Geater, V Chongsuvivatwong, EB McNeil. Factors associated with the doctor–patient relationship: doctor and patient perspectives in hospital outpatient clinics of Inner Mongolia Autonomous Region, China. Patient Preference and Adherence 2019;13: 1125–1143.
[20] Luo Y, Zhao Y, Chen K, Shen J, Shi J, Lu S, et al. Clinical analysis of cervical lymph node metastasis risk factors in patients with papillary thyroid microcarcinoma. J Endocrinol Invest. 2019; 42(2):227–236.
[21] Back K, Kim JS, Kim JH, Choe JH. Superior Located Papillary Thyroid Microcarcinoma is a Risk Factor for Lateral Lymph Node Metastasis. Ann Surg Oncol.2019; 26(12):3992–4001.
[22] Kitahara CM, Sosa JA. The changing incidence of thyroid cancer. Nat. Rev. Endocrinology. 2016;12: 646–653.
[23] Roh JL, Park JY, Park CI. Prevention of postoperative hypocalcemia with routine oral calcium and vitamin D supplementsin patients with differentiated papillary thyroid carcinoma undergoing total thyroidectomy plus central neck dissection.Cancer.2019; 115(2):251–258.
[24] Ahn JE, Lee JH, Yi JS, et al. Diagnostic accuracy of CT and ultrasonography for evaluating metastatic cervical lymph nodes in patients with thyroid cancer. World J Surg. 2008;32:1552–8.
[25] Hwang HS, Orloff LA. Efficacy of preoperative neck ultrasound in the detection of cervical lymph node metastasis from thyroid cancer. Laryngoscope.2010;121(3) : 487–491.
[26] Hegedus L. Thyroid ultrasound. Endocrinol Metab Clin North Am. 2001;30(2):339–360, viii–ix.
[27] Patron V, Bedfert C, Le Clech G, et al. Pattern of lateral neck metastases in N0 papillary thyroid carcinoma. BMC Cancer. 2011;11:8.
[28] Ito Y, Higashiyama T, Takamura Y, Miya A, Kobayashi K, Matsuzuka F, et al. Risk factors for recurrence to the lymph node in papillary thyroid carcinoma patients without preoperatively detectable lateral node metastasis: validity of prophylactic modified radical neck dissection. World J Surg. 2007;31(11):2085-91.
[29] Sippel RS, Chen H. Controversies in the surgical management of newly diagnosed and recurrent/residual thyroid cancer. Thyroid. 2009;19(12):1373-80.
[30] Glenn JA, Yen TW, Fareau GG, Carr AA, Evans DB, Wang TS. Institutional
experience with lateral neck dissections for thyroid cancer. Surgery. 2015;158(4): 972-8. discussion 978-980.
[31] Wu MH, Shen WT, Gosnell J, Duh QY. Prognostic significance of extranodal extension of regional lymph node metastasis in papillary thyroid cancer. Head Neck 2015;37(9):1336-43.
[32] de Meer SG, Dauwan M, de Keizer B, Valk GD, Borel Rinkes IH, Vriens MR. Not the number but the location of lymph nodes matters for recurrence rate and disease-free survival in patients with differentiated thyroid cancer. World J Surg. 2012;36(6):1262-7.
[33] Davidson HC, Park BJ, Johnson JT. Papillary thyroid cancer: controversies in the management of neck metastasis. Laryngoscope. 2008;118(12):2161-5.
[34] Giordano D, Frasoldati A, Kasperbauer JL, Gabrielli E, Pernice C, Zini M, et al. Lateral neck recurrence from papillary thyroid carcinoma: predictive factors and prognostic significance. Laryngoscope. 2015;125(9):2226-31.
[35] Hartl DM, Mamelle E, Borget I, Leboulleux S, Mirghani H, Schlumberger M. Influence of prophylactic neck dissection on rate of retreatment for papillary thyroid carcinoma. World J Surg .2013;37(8):1951-1958.
[36] Hartl DM, Leboulleux S, Al Ghuzlan A, Baudin E, Chami L, Schlumberger M, et al. Optimization of staging of the neck with prophylactic central and lateral neck dissection for papillary thyroid carcinoma. Ann Surg 2012;255(4):777-83.
[37] Park YM, Wang SG, Shin DH, Kim IJ, Son SM, Lee BJ. Lymph node status of lateral neck compartment in patients with N1b papillary thyroid carcinoma. Acta Otolaryngol 2016;136(3):319-324.
[38] Bonnet S, Hartl D, Leboulleux S, Baudin E, Lumbroso JD, Al Ghuzlan A, et al. Prophylactic lymph node dissection for papillary thyroid cancer less than 2 cm: implications for radioiodine treatment. J Clin Endocrinol Metab. 2009;94(4): 1162-1167.
[39] Hei H, Song Y, Qin J.A Nomogram Predicting Contralateral Central Neck Lymph Node Metastasis for Papillary Thyroid Carcinoma, J Surg Oncol. 2016;114(6):703-707.